Feedback / Questions
T3011 - ImmVira Pharma
https://www.prnewswire.com/news-releases/high-response-in-bladder-cancer-immvira-announced-its-mvr-t3011-latest-clinical-results-in-bcg-unresponsive-bladder-cancer-patients-at-2025-annual-meeting-of-the-society-of-urologic-oncology-302631544.html
Dec 3, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next